• Sonia Pagliusi, Luciana C C Leite, Mahima Datla, Morena Makhoana, Yongzhong Gao, Mahendra Suhardono, Suresh Jadhav, Gutla V J A Harshavardhan, and Akira Homma.
• DCVMN International, Chemin du Canal 5, 1260 Nyon, Switzerland. s.pagliusi@dcvmn.org
• Vaccine. 2013 Apr 18;31 Suppl 2:B176-83.

AbstractThe Developing Countries Vaccine Manufacturers Network (DCVMN) is a unique model of a public and private international alliance. It assembles governmental and private organizations to work toward a common goal of manufacturing and supplying high-quality vaccines at affordable prices to protect people around the world from known and emerging infectious diseases. Together, this group of manufacturers has decades of experience in manufacturing vaccines, with technologies, know-how, and capacity to produce more than 40 vaccines types. These manufacturers have already contributed more than 30 vaccines in various presentations that have been prequalified by the World Health Organization for use by global immunization programmes. Furthermore, more than 45 vaccines are in the pipeline. Recent areas of focus include vaccines to protect against rotavirus, human papillomavirus (HPV), Japanese encephalitis, meningitis, hepatitis E, poliovirus, influenza, and pertussis, as well as combined pentavalent vaccines for children. The network has a growing number of manufacturers that produce a growing number of products to supply the growing demand for vaccines in developing countries.Copyright © 2013. Published by Elsevier Ltd.

9 keywords...

hide…